hey Matt/Sidage am keen to see the articles around numbers reported from other clinics that you mention. not disputing it at all, just would like to read.
despite our enthralling discussion, any presentation to investors by EMD makes it clear the patient numbers aren’t the focus. this facet of the business of only there to wash its face and provide a platform for the data aspect where there is substantial upside potential. also interesting applications for the EMD platform outside of cannabis too.
EMD Price at posting:
6.6¢ Sentiment: Buy Disclosure: Held
